|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
500 |
0.37 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.42 |
Functional ≤ 10μM
|
Z80055-1-O |
CAKI-1 (Kidney Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
40 |
0.43 |
Functional ≤ 10μM
|
Z80089-1-O |
CHO-AA8 (cluster #1 Of 2), Other |
Other |
1 |
0.53 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
450 |
0.37 |
Functional ≤ 10μM
|
Z80115-1-O |
DC3F (cluster #1 Of 1), Other |
Other |
82 |
0.41 |
Functional ≤ 10μM
|
Z80117-1-O |
DC3F/AD-II (cluster #1 Of 2), Other |
Other |
110 |
0.41 |
Functional ≤ 10μM
|
Z80125-8-O |
DU-145 (Prostate Carcinoma) (cluster #8 Of 9), Other |
Other |
170 |
0.39 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
50 |
0.43 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
99 |
0.41 |
Functional ≤ 10μM |
Z80186-4-O |
K562 (Erythroleukemia Cells) (cluster #4 Of 11), Other |
Other |
470 |
0.37 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
90 |
0.41 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
960 |
0.35 |
Functional ≤ 10μM
|
Z80244-3-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #3 Of 7), Other |
Other |
270 |
0.38 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
51 |
0.43 |
Functional ≤ 10μM
|
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
535 |
0.37 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
48 |
0.43 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
1500 |
0.34 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
200 |
0.39 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
993 |
0.35 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
200 |
0.39 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
7 |
0.48 |
Functional ≤ 10μM
|
Z80647-1-O |
833K Cell Line (cluster #1 Of 1), Other |
Other |
328 |
0.38 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
4500 |
0.31 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
400 |
0.37 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
40 |
0.43 |
Functional ≤ 10μM
|
Z80776-1-O |
Clone 62 Cell Line (cluster #1 Of 1), Other |
Other |
1500 |
0.34 |
Functional ≤ 10μM
|
Z80888-1-O |
H2987 Cell Line (cluster #1 Of 1), Other |
Other |
1600 |
0.34 |
Functional ≤ 10μM
|
Z80951-1-O |
NIH3T3 (Fibroblasts) (cluster #1 Of 4), Other |
Other |
1700 |
0.34 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
10 |
0.47 |
Functional ≤ 10μM
|
Z81020-2-O |
HepG2 (Hepatoblastoma Cells) (cluster #2 Of 8), Other |
Other |
5400 |
0.31 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
50 |
0.43 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
600 |
0.36 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
810 |
0.36 |
Functional ≤ 10μM
|
Z81264-1-O |
V79 (Lung Fibroblasts) (cluster #1 Of 2), Other |
Other |
800 |
0.36 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
70 |
0.42 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
4030 |
0.31 |
ADME/T ≤ 10μM
|
Z81264-1-O |
V79 (Lung Fibroblasts) (cluster #1 Of 2), Other |
Other |
400 |
0.37 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.23 |
-4.19 |
-10.5 |
4 |
9 |
0 |
145 |
334.332 |
4 |
↓
|
Mid
Mid (pH 6-8)
|
-1.23 |
-4.19 |
-11.87 |
4 |
9 |
0 |
145 |
334.332 |
4 |
↓
|
|
|
Analogs
-
4212843
-
-
607790
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 53 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Q862F3-2-E |
Tubulin Alpha Chain (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2500 |
0.27 |
Binding ≤ 10μM |
Q862L2-2-E |
Tubulin Alpha-1 Chain (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2500 |
0.27 |
Binding ≤ 10μM |
TBA1A-1-E |
Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
5750 |
0.25 |
Binding ≤ 10μM
|
TBA4A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2700 |
0.27 |
Binding ≤ 10μM
|
TBB-1-E |
Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1260 |
0.28 |
Binding ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
800 |
0.29 |
Binding ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
780 |
0.29 |
Binding ≤ 10μM
|
TBB3-1-E |
Tubulin Beta-3 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5750 |
0.25 |
Binding ≤ 10μM
|
TBB4A-1-E |
Tubulin Beta-4 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.30 |
Binding ≤ 10μM
|
TBB4B-1-E |
Tubulin Beta-2 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.30 |
Binding ≤ 10μM
|
TBB5-1-E |
Tubulin Beta-5 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5750 |
0.25 |
Binding ≤ 10μM
|
TBB8-1-E |
Tubulin Beta-8 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.30 |
Binding ≤ 10μM
|
TBG1-1-E |
Tubulin Gamma-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5750 |
0.25 |
Binding ≤ 10μM
|
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8700 |
0.24 |
Functional ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8700 |
0.24 |
Functional ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
800 |
0.29 |
Functional ≤ 10μM
|
TBA4A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1700 |
0.28 |
Functional ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
800 |
0.29 |
Functional ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8700 |
0.24 |
Functional ≤ 10μM
|
TBB3-1-E |
Tubulin Beta-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4200 |
0.26 |
Functional ≤ 10μM
|
TBB4A-1-E |
Tubulin Beta-4 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4200 |
0.26 |
Functional ≤ 10μM
|
TBB4B-1-E |
Tubulin Beta-2 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4200 |
0.26 |
Functional ≤ 10μM
|
TBB5-1-E |
Tubulin Beta-5 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3300 |
0.26 |
Functional ≤ 10μM
|
TBB8-1-E |
Tubulin Beta-8 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4200 |
0.26 |
Functional ≤ 10μM
|
Z101682-1-O |
BK Polyomavirus (cluster #1 Of 2), Other |
Other |
22 |
0.37 |
Functional ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
20 |
0.37 |
Functional ≤ 10μM |
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
53 |
0.35 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
10000 |
0.24 |
Functional ≤ 10μM
|
Z50590-1-O |
Sus Scrofa (cluster #1 Of 1), Other |
Other |
1400 |
0.28 |
Functional ≤ 10μM
|
Z50607-1-O |
Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other |
Other |
18 |
0.37 |
Functional ≤ 10μM |
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
12 |
0.38 |
Functional ≤ 10μM
|
Z80024-1-O |
A9 (Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
14 |
0.38 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.36 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
31 |
0.36 |
Functional ≤ 10μM
|
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
220 |
0.32 |
Functional ≤ 10μM |
Z80096-1-O |
CHO-TAX 5-6 (cluster #1 Of 2), Other |
Other |
140 |
0.33 |
Functional ≤ 10μM |
Z80097-1-O |
CHO-VV 3-2 (cluster #1 Of 2), Other |
Other |
620 |
0.30 |
Functional ≤ 10μM |
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
190 |
0.32 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
10 |
0.39 |
Functional ≤ 10μM |
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
53 |
0.35 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
1 |
0.43 |
Functional ≤ 10μM |
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
22 |
0.37 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
7 |
0.39 |
Functional ≤ 10μM |
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
7 |
0.39 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
6 |
0.40 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
1900 |
0.28 |
Functional ≤ 10μM |
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.39 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
15 |
0.38 |
Functional ≤ 10μM
|
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
800 |
0.29 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
10 |
0.39 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
33 |
0.36 |
Functional ≤ 10μM |
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
14 |
0.38 |
Functional ≤ 10μM
|
Z80427-1-O |
RKO (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
20 |
0.37 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM |
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
5 |
0.40 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
71 |
0.35 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
30 |
0.36 |
Functional ≤ 10μM |
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
5 |
0.40 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
390 |
0.31 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
6 |
0.40 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
45 |
0.35 |
Functional ≤ 10μM
|
Z80711-1-O |
NCI/ADR-RES (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
1113 |
0.29 |
Functional ≤ 10μM |
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
9 |
0.39 |
Functional ≤ 10μM
|
Z80720-1-O |
Burkitts Lymphoma Cells (cluster #1 Of 1), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
52 |
0.35 |
Functional ≤ 10μM |
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
3 |
0.41 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
8 |
0.39 |
Functional ≤ 10μM |
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
40 |
0.36 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM |
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
70 |
0.35 |
Functional ≤ 10μM |
Z81054-2-O |
SF-268 (Glioblastoma Cells) (cluster #2 Of 3), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
17 |
0.38 |
Functional ≤ 10μM |
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
6 |
0.40 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
20 |
0.37 |
Functional ≤ 10μM |
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
93 |
0.34 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
7 |
0.39 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
39 |
0.36 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.35 |
Functional ≤ 10μM
|
Z81281-1-O |
NCI-H23 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 5), Other |
Other |
13 |
0.38 |
Functional ≤ 10μM |
Z81283-1-O |
NCI-H522 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
14 |
0.38 |
Functional ≤ 10μM |
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
14 |
0.38 |
Functional ≤ 10μM |
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
140 |
0.33 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
530 |
0.30 |
ADME/T ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
522 |
0.30 |
ADME/T ≤ 10μM
|
Z80897-1-O |
H9 (T-lymphoid Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.39 |
ADME/T ≤ 10μM |
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
3 |
0.41 |
ADME/T ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 3), Other |
Other |
210 |
0.32 |
ADME/T ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
2 |
0.42 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.10 |
7.99 |
-20.74 |
1 |
7 |
0 |
83 |
399.443 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TBA1A-1-E |
Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
370 |
0.36 |
Binding ≤ 10μM
|
TBB-1-E |
Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
370 |
0.36 |
Binding ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
670 |
0.35 |
Functional ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
670 |
0.35 |
Functional ≤ 10μM
|
Z50590-1-O |
Sus Scrofa (cluster #1 Of 1), Other |
Other |
700 |
0.34 |
Functional ≤ 10μM
|
Z80186-2-O |
K562 (Erythroleukemia Cells) (cluster #2 Of 11), Other |
Other |
206 |
0.37 |
Functional ≤ 10μM
|
Z80193-1-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #1 Of 12), Other |
Other |
140 |
0.38 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
10 |
0.45 |
Functional ≤ 10μM
|
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
260 |
0.37 |
Functional ≤ 10μM
|
Z80427-1-O |
RKO (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
60 |
0.40 |
Functional ≤ 10μM
|
Z80441-1-O |
RXF 944 (cluster #1 Of 1), Other |
Other |
10 |
0.45 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
50 |
0.41 |
Functional ≤ 10μM
|
Z81006-1-O |
Human Breast 401NL Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.45 |
Functional ≤ 10μM
|
Z81024-5-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #5 Of 8), Other |
Other |
70 |
0.40 |
Functional ≤ 10μM
|
Z81025-1-O |
Human Lung LXF 529L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
520 |
0.35 |
Functional ≤ 10μM
|
Z81026-1-O |
Human Lung LXF 629L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.45 |
Functional ≤ 10μM
|
Z81054-2-O |
SF-268 (Glioblastoma Cells) (cluster #2 Of 3), Other |
Other |
50 |
0.41 |
Functional ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
90 |
0.39 |
Functional ≤ 10μM
|
Z81187-1-O |
LT12 Tumor Cell Line (cluster #1 Of 1), Other |
Other |
320 |
0.36 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.86 |
8.97 |
-14.3 |
1 |
3 |
0 |
47 |
328.367 |
2 |
↓
|
|
|
Analogs
-
16957840
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 7 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.69 |
2.46 |
-149.31 |
0 |
8 |
-2 |
109 |
394.316 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.89 |
7.44 |
-9.46 |
1 |
3 |
0 |
42 |
251.285 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.39 |
-0.87 |
-11.82 |
1 |
2 |
0 |
32 |
221.259 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.27 |
-0.66 |
-50.22 |
2 |
4 |
1 |
46 |
328.823 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.30 |
5.16 |
-16.72 |
2 |
10 |
0 |
127 |
377.43 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.81 |
8.79 |
-9.53 |
3 |
5 |
0 |
77 |
330.391 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.43 |
7.88 |
-9.85 |
3 |
5 |
0 |
77 |
316.364 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.17 |
9.25 |
-9.05 |
3 |
5 |
0 |
77 |
344.418 |
3 |
↓
|
|
|
Analogs
-
3917708
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
40 |
0.27 |
Binding ≤ 10μM |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.21 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 2), Other |
Other |
2600 |
0.20 |
Binding ≤ 10μM
|
Z103196-1-O |
22RV1 (cluster #1 Of 2), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM |
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
130 |
0.25 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
370 |
0.23 |
Functional ≤ 10μM
|
Z103219-1-O |
Ca9-22 (cluster #1 Of 1), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM
|
Z50347-3-O |
Saccharomyces Cerevisiae (cluster #3 Of 3), Other |
Other |
10000 |
0.18 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 5), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
53 |
0.26 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
310 |
0.23 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z80039-1-O |
BGC-823 (Stomach Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
6000 |
0.19 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80105-2-O |
COR-L23 (Lung Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
319 |
0.23 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
2540 |
0.20 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6240 |
0.19 |
Functional ≤ 10μM |
Z80126-2-O |
DuPro (cluster #2 Of 2), Other |
Other |
1800 |
0.21 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
870 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
940 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
4700 |
0.19 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
9320 |
0.18 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
92 |
0.25 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
950 |
0.22 |
Functional ≤ 10μM
|
Z80175-1-O |
IMR-32 (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
430 |
0.23 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
21 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9700 |
0.18 |
Functional ≤ 10μM
|
Z80214-2-O |
M14 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
Functional ≤ 10μM
|
Z80243-1-O |
MDA-MB-453 (Breast Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.29 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
704 |
0.22 |
Functional ≤ 10μM
|
Z80267-1-O |
MKN-1 (cluster #1 Of 1), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3130 |
0.20 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z80330-1-O |
NCI-N87 (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
Functional ≤ 10μM
|
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
17 |
0.28 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
830 |
0.22 |
Functional ≤ 10μM |
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
13 |
0.28 |
Functional ≤ 10μM
|
Z80389-1-O |
PC-14 (cluster #1 Of 1), Other |
Other |
290 |
0.23 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
680 |
0.22 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
912 |
0.22 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
560 |
0.22 |
Functional ≤ 10μM
|
Z80441-1-O |
RXF 944 (cluster #1 Of 1), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80472-1-O |
SiHa (Cervical Squamous Cell Carcinoma) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80477-1-O |
SK_HEP1 (Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80479-1-O |
SK-MEL (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1730 |
0.21 |
Functional ≤ 10μM
|
Z80481-1-O |
SK-MEL-1 (Metastatic Melanoma Cells) (cluster #1 Of 1), Other |
Other |
3092 |
0.20 |
Functional ≤ 10μM |
Z80482-3-O |
SK-MEL-2 (Melanoma Cells) (cluster #3 Of 4), Other |
Other |
97 |
0.25 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80492-1-O |
SK-N-SH (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
800 |
0.22 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
6540 |
0.19 |
Functional ≤ 10μM
|
Z80503-1-O |
SNU1 (cluster #1 Of 2), Other |
Other |
4000 |
0.19 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
690 |
0.22 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80574-2-O |
UMUC3 (cluster #2 Of 2), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
699 |
0.22 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
5000 |
0.19 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM |
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
44 |
0.26 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80640-1-O |
786-0 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
3100 |
0.20 |
Functional ≤ 10μM |
Z80661-1-O |
A704 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
540 |
0.22 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
970 |
0.22 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
72 |
0.26 |
Functional ≤ 10μM
|
Z80726-1-O |
TRAMP-C1A (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
76 |
0.26 |
Functional ≤ 10μM
|
Z80730-1-O |
C2D Cell Line (cluster #1 Of 1), Other |
Other |
47 |
0.26 |
Functional ≤ 10μM
|
Z80731-1-O |
C2G Cell Line (cluster #1 Of 1), Other |
Other |
29 |
0.27 |
Functional ≤ 10μM
|
Z80732-1-O |
TRAMP-C2H (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80735-1-O |
C38 (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.23 |
Functional ≤ 10μM
|
Z80801-2-O |
CRL-7065 Cell Line (cluster #2 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
368 |
0.23 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
27 |
0.27 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
6810 |
0.19 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80943-1-O |
HEL 299 (cluster #1 Of 1), Other |
Other |
1700 |
0.21 |
Functional ≤ 10μM |
Z80945-1-O |
HEp-2 (Laryngeal Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
59 |
0.26 |
Functional ≤ 10μM
|
Z81005-1-O |
HTB-54 Cell Line (cluster #1 Of 1), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z81006-1-O |
Human Breast 401NL Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
954 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
1290 |
0.21 |
Functional ≤ 10μM |
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
660 |
0.22 |
Functional ≤ 10μM
|
Z81025-1-O |
Human Lung LXF 529L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z81026-1-O |
Human Lung LXF 629L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81028-1-O |
Human Melanoma Cell Line (cluster #1 Of 1), Other |
Other |
280 |
0.24 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z81101-1-O |
KBM-3 Cell Line (cluster #1 Of 1), Other |
Other |
26 |
0.27 |
Functional ≤ 10μM
|
Z81102-1-O |
KBM-3/DOX Cell Line (cluster #1 Of 1), Other |
Other |
490 |
0.23 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
7010 |
0.19 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
315 |
0.23 |
Functional ≤ 10μM |
Z81134-1-O |
L2987 (Lung Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
78 |
0.26 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
42 |
0.26 |
Functional ≤ 10μM
|
Z81201-1-O |
HOP-62 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
4 |
0.30 |
Functional ≤ 10μM
|
Z81211-1-O |
LXFL529 Cell Line (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
79 |
0.25 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
960 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
710 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
730 |
0.22 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
840 |
0.22 |
Functional ≤ 10μM
|
Z81257-1-O |
MEL-AC Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.21 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
112 |
0.25 |
Functional ≤ 10μM
|
Z81277-2-O |
NCI-N417 (cluster #2 Of 2), Other |
Other |
230 |
0.24 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
1 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
2320 |
0.20 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
74 |
0.26 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
ADME/T ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80005-1-O |
3T3 (Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
3700 |
0.19 |
ADME/T ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.22 |
ADME/T ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
480 |
0.23 |
ADME/T ≤ 10μM
|
Z80178-2-O |
J774.A1 (Macrophage Cells) (cluster #2 Of 2), Other |
Other |
20 |
0.28 |
ADME/T ≤ 10μM |
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80193-3-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
29 |
0.27 |
ADME/T ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
ADME/T ≤ 10μM
|
Z80253-2-O |
MEF (Embryonic Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
3400 |
0.20 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
300 |
0.23 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.20 |
ADME/T ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
8 |
0.29 |
ADME/T ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
7400 |
0.18 |
ADME/T ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
900 |
0.22 |
ADME/T ≤ 10μM
|
Z80704-1-O |
BJ (Foreskin Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
2700 |
0.20 |
ADME/T ≤ 10μM
|
Z80936-4-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #4 Of 4), Other |
Other |
64 |
0.26 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
ADME/T ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
ADME/T ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
7 |
0.29 |
ADME/T ≤ 10μM
|
Z81057-5-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #5 Of 5), Other |
Other |
30 |
0.27 |
ADME/T ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 3), Other |
Other |
400 |
0.23 |
ADME/T ≤ 10μM
|
Z81331-2-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
178 |
0.24 |
ADME/T ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
900 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.57 |
-0.88 |
-58.15 |
8 |
12 |
1 |
208 |
544.533 |
5 |
↓
|
|
|
Analogs
-
3830631
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
40 |
0.27 |
Binding ≤ 10μM |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.21 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 2), Other |
Other |
2600 |
0.20 |
Binding ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
130 |
0.25 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
370 |
0.23 |
Functional ≤ 10μM
|
Z103219-1-O |
Ca9-22 (cluster #1 Of 1), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM
|
Z50347-3-O |
Saccharomyces Cerevisiae (cluster #3 Of 3), Other |
Other |
10000 |
0.18 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 5), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
53 |
0.26 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
310 |
0.23 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z80039-1-O |
BGC-823 (Stomach Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
6000 |
0.19 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80105-2-O |
COR-L23 (Lung Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
319 |
0.23 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6240 |
0.19 |
Functional ≤ 10μM |
Z80126-2-O |
DuPro (cluster #2 Of 2), Other |
Other |
1800 |
0.21 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
870 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
9320 |
0.18 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
92 |
0.25 |
Functional ≤ 10μM
|
Z80175-1-O |
IMR-32 (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
21 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9700 |
0.18 |
Functional ≤ 10μM
|
Z80214-2-O |
M14 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
Functional ≤ 10μM
|
Z80243-1-O |
MDA-MB-453 (Breast Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.29 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
704 |
0.22 |
Functional ≤ 10μM
|
Z80267-1-O |
MKN-1 (cluster #1 Of 1), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3130 |
0.20 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z80330-1-O |
NCI-N87 (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
Functional ≤ 10μM
|
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
830 |
0.22 |
Functional ≤ 10μM |
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
13 |
0.28 |
Functional ≤ 10μM
|
Z80389-1-O |
PC-14 (cluster #1 Of 1), Other |
Other |
290 |
0.23 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
912 |
0.22 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
560 |
0.22 |
Functional ≤ 10μM
|
Z80441-1-O |
RXF 944 (cluster #1 Of 1), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80472-1-O |
SiHa (Cervical Squamous Cell Carcinoma) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80477-1-O |
SK_HEP1 (Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80479-1-O |
SK-MEL (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1730 |
0.21 |
Functional ≤ 10μM
|
Z80481-1-O |
SK-MEL-1 (Metastatic Melanoma Cells) (cluster #1 Of 1), Other |
Other |
3092 |
0.20 |
Functional ≤ 10μM |
Z80482-3-O |
SK-MEL-2 (Melanoma Cells) (cluster #3 Of 4), Other |
Other |
97 |
0.25 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80492-1-O |
SK-N-SH (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
800 |
0.22 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
6540 |
0.19 |
Functional ≤ 10μM
|
Z80503-1-O |
SNU1 (cluster #1 Of 2), Other |
Other |
4000 |
0.19 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
690 |
0.22 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80574-2-O |
UMUC3 (cluster #2 Of 2), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
699 |
0.22 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
5000 |
0.19 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM |
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
44 |
0.26 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80661-1-O |
A704 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
970 |
0.22 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
72 |
0.26 |
Functional ≤ 10μM
|
Z80726-1-O |
TRAMP-C1A (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
76 |
0.26 |
Functional ≤ 10μM
|
Z80730-1-O |
C2D Cell Line (cluster #1 Of 1), Other |
Other |
47 |
0.26 |
Functional ≤ 10μM
|
Z80731-1-O |
C2G Cell Line (cluster #1 Of 1), Other |
Other |
29 |
0.27 |
Functional ≤ 10μM
|
Z80732-1-O |
TRAMP-C2H (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80735-1-O |
C38 (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.23 |
Functional ≤ 10μM
|
Z80801-2-O |
CRL-7065 Cell Line (cluster #2 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
368 |
0.23 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
27 |
0.27 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80943-1-O |
HEL 299 (cluster #1 Of 1), Other |
Other |
1700 |
0.21 |
Functional ≤ 10μM |
Z80945-1-O |
HEp-2 (Laryngeal Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
59 |
0.26 |
Functional ≤ 10μM
|
Z81005-1-O |
HTB-54 Cell Line (cluster #1 Of 1), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z81006-1-O |
Human Breast 401NL Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
954 |
0.22 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
660 |
0.22 |
Functional ≤ 10μM
|
Z81025-1-O |
Human Lung LXF 529L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z81026-1-O |
Human Lung LXF 629L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81028-1-O |
Human Melanoma Cell Line (cluster #1 Of 1), Other |
Other |
280 |
0.24 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z81101-1-O |
KBM-3 Cell Line (cluster #1 Of 1), Other |
Other |
26 |
0.27 |
Functional ≤ 10μM
|
Z81102-1-O |
KBM-3/DOX Cell Line (cluster #1 Of 1), Other |
Other |
490 |
0.23 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
7010 |
0.19 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
315 |
0.23 |
Functional ≤ 10μM |
Z81134-1-O |
L2987 (Lung Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
78 |
0.26 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
42 |
0.26 |
Functional ≤ 10μM
|
Z81201-1-O |
HOP-62 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
4 |
0.30 |
Functional ≤ 10μM
|
Z81211-1-O |
LXFL529 Cell Line (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
79 |
0.25 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
960 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
730 |
0.22 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81257-1-O |
MEL-AC Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.21 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
112 |
0.25 |
Functional ≤ 10μM
|
Z81277-2-O |
NCI-N417 (cluster #2 Of 2), Other |
Other |
230 |
0.24 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
1 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
74 |
0.26 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
ADME/T ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80005-1-O |
3T3 (Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
3700 |
0.19 |
ADME/T ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.22 |
ADME/T ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
480 |
0.23 |
ADME/T ≤ 10μM
|
Z80178-2-O |
J774.A1 (Macrophage Cells) (cluster #2 Of 2), Other |
Other |
20 |
0.28 |
ADME/T ≤ 10μM |
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80193-3-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
29 |
0.27 |
ADME/T ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
ADME/T ≤ 10μM
|
Z80253-2-O |
MEF (Embryonic Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
3400 |
0.20 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
300 |
0.23 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.20 |
ADME/T ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
8 |
0.29 |
ADME/T ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
7400 |
0.18 |
ADME/T ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
900 |
0.22 |
ADME/T ≤ 10μM
|
Z80704-1-O |
BJ (Foreskin Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
2700 |
0.20 |
ADME/T ≤ 10μM
|
Z80936-4-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #4 Of 4), Other |
Other |
64 |
0.26 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
ADME/T ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
ADME/T ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
7 |
0.29 |
ADME/T ≤ 10μM
|
Z81057-5-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #5 Of 5), Other |
Other |
30 |
0.27 |
ADME/T ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 3), Other |
Other |
400 |
0.23 |
ADME/T ≤ 10μM
|
Z81331-2-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
178 |
0.24 |
ADME/T ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
900 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.57 |
-0.9 |
-63.19 |
8 |
12 |
1 |
208 |
544.533 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
NEK2-1-E |
Serine/threonine-protein Kinase NEK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
21 |
0.31 |
Binding ≤ 10μM
|
NUAK1-1-E |
NUAK Family SNF1-like Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2000 |
0.23 |
Binding ≤ 10μM
|
PGFRB-1-E |
Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
420 |
0.26 |
Binding ≤ 10μM
|
PIM1-1-E |
Serine/threonine-protein Kinase PIM1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
310 |
0.26 |
Binding ≤ 10μM
|
PK3CD-2-E |
PI3-kinase P110-delta Subunit (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
440 |
0.25 |
Binding ≤ 10μM
|
PLK1-1-E |
Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
PLK3-1-E |
Serine/threonine-protein Kinase PLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
630 |
0.25 |
Binding ≤ 10μM
|
VGFR2-1-E |
Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1200 |
0.24 |
Binding ≤ 10μM
|
Z100745-1-O |
MX1 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
9 |
0.32 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
3 |
0.34 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
11 |
0.32 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
11 |
0.32 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
11 |
0.32 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.33 |
12.96 |
-50.54 |
3 |
7 |
1 |
84 |
512.055 |
7 |
↓
|
Hi
High (pH 8-9.5)
|
4.33 |
10.56 |
-12.27 |
2 |
7 |
0 |
83 |
511.047 |
7 |
↓
|
Lo
Low (pH 4.5-6)
|
4.33 |
13.44 |
-95.41 |
4 |
7 |
2 |
85 |
513.063 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
2 |
0.45 |
Functional ≤ 10μM |
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
19 |
0.40 |
Functional ≤ 10μM |
Z103208-1-O |
AU565 (cluster #1 Of 1), Other |
Other |
6 |
0.43 |
Functional ≤ 10μM |
Z80125-9-O |
DU-145 (Prostate Carcinoma) (cluster #9 Of 9), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM |
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
2 |
0.45 |
Functional ≤ 10μM |
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
1 |
0.47 |
Functional ≤ 10μM |
Z80640-1-O |
786-0 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
1 |
0.47 |
Functional ≤ 10μM |
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM |
Z81057-1-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #1 Of 4), Other |
Other |
25 |
0.39 |
Functional ≤ 10μM |
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
1 |
0.47 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.04 |
5.12 |
-14.92 |
1 |
7 |
0 |
87 |
372.373 |
6 |
↓
|
Hi
High (pH 8-9.5)
|
3.04 |
6.04 |
-56.69 |
0 |
7 |
-1 |
90 |
371.365 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 5 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AAK1-1-E |
Adaptor-associated Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
200 |
0.35 |
Binding ≤ 10μM
|
AAPK1-1-E |
AMP-activated Protein Kinase, Alpha-1 Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1700 |
0.30 |
Binding ≤ 10μM
|
AAPK2-1-E |
AMP-activated Protein Kinase, Alpha-2 Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1800 |
0.30 |
Binding ≤ 10μM
|
ABL1-1-E |
Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
820 |
0.32 |
Binding ≤ 10μM
|
ACVL1-1-E |
Serine/threonine-protein Kinase Receptor R3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2900 |
0.29 |
Binding ≤ 10μM
|
ACVR1-1-E |
Activin Receptor Type-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5900 |
0.27 |
Binding ≤ 10μM
|
ADCK3-1-E |
Chaperone Activity Of Bc1 Complex-like, Mitochondrial (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1200 |
0.31 |
Binding ≤ 10μM
|
ALK-1-E |
ALK Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7100 |
0.27 |
Binding ≤ 10μM
|
ANKK1-1-E |
Ankyrin Repeat And Protein Kinase Domain-containing Protein 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.33 |
Binding ≤ 10μM
|
AURKA-3-E |
Serine/threonine-protein Kinase Aurora-A (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
250 |
0.34 |
Binding ≤ 10μM
|
AURKB-1-E |
Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
160 |
0.35 |
Binding ≤ 10μM
|
AURKC-1-E |
Serine/threonine-protein Kinase Aurora-C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
86 |
0.37 |
Binding ≤ 10μM
|
AVR2A-1-E |
Activin Receptor Type-2A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2900 |
0.29 |
Binding ≤ 10μM
|
AVR2B-1-E |
Activin Receptor Type-2B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5900 |
0.27 |
Binding ≤ 10μM
|
BMP2K-1-E |
BMP-2-inducible Protein Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
180 |
0.35 |
Binding ≤ 10μM
|
BMPR2-1-E |
Bone Morphogenetic Protein Receptor Type-2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
880 |
0.31 |
Binding ≤ 10μM
|
BMX-1-E |
Tyrosine-protein Kinase BMX (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4700 |
0.28 |
Binding ≤ 10μM
|
BRSK1-1-E |
BR Serine/threonine-protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6500 |
0.27 |
Binding ≤ 10μM
|
BRSK2-1-E |
BR Serine/threonine-protein Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2700 |
0.29 |
Binding ≤ 10μM
|
CCNA1-1-E |
Cyclin A1 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2 |
0.45 |
Binding ≤ 10μM
|
CCNA2-1-E |
Cyclin A2 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2 |
0.45 |
Binding ≤ 10μM
|
CCNB1-1-E |
G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.43 |
Binding ≤ 10μM
|
CCNB2-1-E |
G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.43 |
Binding ≤ 10μM
|
CCNB3-1-E |
G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.43 |
Binding ≤ 10μM
|
CD11A-1-E |
PITSLRE Serine/threonine-protein Kinase CDC2L2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
110 |
0.36 |
Binding ≤ 10μM
|
CD11B-1-E |
PITSLRE Serine/threonine-protein Kinase CDC2L1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
150 |
0.35 |
Binding ≤ 10μM
|
CDK1-1-E |
Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
6 |
0.43 |
Binding ≤ 10μM
|
CDK14-1-E |
Serine/threonine-protein Kinase PFTAIRE-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3600 |
0.28 |
Binding ≤ 10μM
|
CDK16-1-E |
Serine/threonine-protein Kinase PCTAIRE-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
23 |
0.40 |
Binding ≤ 10μM
|
CDK17-1-E |
Serine/threonine-protein Kinase PCTAIRE-2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
290 |
0.34 |
Binding ≤ 10μM
|
CDK18-1-E |
Serine/threonine-protein Kinase PCTAIRE-3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2100 |
0.29 |
Binding ≤ 10μM
|
CDK2-1-E |
Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
23 |
0.40 |
Binding ≤ 10μM
|
CDK3-1-E |
Cyclin-dependent Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
180 |
0.35 |
Binding ≤ 10μM
|
CDK5-1-E |
Cyclin-dependent Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
240 |
0.34 |
Binding ≤ 10μM
|
CDK7-1-E |
Cyclin-dependent Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
760 |
0.32 |
Binding ≤ 10μM
|
CDK9-1-E |
Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
470 |
0.33 |
Binding ≤ 10μM
|
CLK1-1-E |
Dual Specificty Protein Kinase CLK1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
660 |
0.32 |
Binding ≤ 10μM
|
CLK2-1-E |
Dual Specificity Protein Kinase CLK2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
290 |
0.34 |
Binding ≤ 10μM
|
CLK3-1-E |
Dual Specificity Protein Kinase CLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
310 |
0.34 |
Binding ≤ 10μM
|
CLK4-1-E |
Dual Specificity Protein Kinase CLK4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1700 |
0.30 |
Binding ≤ 10μM
|
CSF1R-1-E |
Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4200 |
0.28 |
Binding ≤ 10μM
|
CSK22-1-E |
Casein Kinase II Alpha (prime) (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2000 |
0.30 |
Binding ≤ 10μM
|
DAPK3-1-E |
Death-associated Protein Kinase 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5200 |
0.27 |
Binding ≤ 10μM
|
DCLK1-1-E |
Serine/threonine-protein Kinase DCLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2500 |
0.29 |
Binding ≤ 10μM
|
DCLK2-1-E |
Serine/threonine-protein Kinase DCLK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4500 |
0.28 |
Binding ≤ 10μM
|
DCLK3-1-E |
Serine/threonine-protein Kinase DCLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6500 |
0.27 |
Binding ≤ 10μM
|
DMPK-1-E |
Myotonin-protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1200 |
0.31 |
Binding ≤ 10μM
|
E2AK2-1-E |
Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6300 |
0.27 |
Binding ≤ 10μM
|
E2AK4-1-E |
Eukaryotic Translation Initiation Factor 2-alpha Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3900 |
0.28 |
Binding ≤ 10μM
|
EPHA7-1-E |
Ephrin Type-A Receptor 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3100 |
0.29 |
Binding ≤ 10μM
|
FGFR1-1-E |
Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
810 |
0.32 |
Binding ≤ 10μM
|
FGFR2-1-E |
Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
680 |
0.32 |
Binding ≤ 10μM
|
FGFR3-1-E |
Fibroblast Growth Factor Receptor 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
690 |
0.32 |
Binding ≤ 10μM
|
FGR-1-E |
Tyrosine-protein Kinase FGR (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2000 |
0.30 |
Binding ≤ 10μM
|
FLT3-1-E |
Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
850 |
0.31 |
Binding ≤ 10μM
|
GAK-1-E |
Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2400 |
0.29 |
Binding ≤ 10μM
|
GSK3A-1-E |
Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
41 |
0.38 |
Binding ≤ 10μM
|
GSK3B-1-E |
Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
950 |
0.31 |
Binding ≤ 10μM
|
IKKE-1-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Epsilon Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8300 |
0.26 |
Binding ≤ 10μM
|
IRAK3-1-E |
Interleukin-1 Receptor-associated Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3400 |
0.28 |
Binding ≤ 10μM
|
JAK1-1-E |
Tyrosine-protein Kinase JAK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
21 |
0.40 |
Binding ≤ 10μM
|
JAK2-1-E |
Tyrosine-protein Kinase JAK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
220 |
0.35 |
Binding ≤ 10μM
|
JAK3-1-E |
Tyrosine-protein Kinase JAK3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
180 |
0.35 |
Binding ≤ 10μM
|
KC1E-1-E |
Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3600 |
0.28 |
Binding ≤ 10μM
|
KC1G1-1-E |
Casein Kinase I Gamma 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1200 |
0.31 |
Binding ≤ 10μM
|
KC1G2-1-E |
Casein Kinase I Gamma 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
740 |
0.32 |
Binding ≤ 10μM
|
KC1G3-1-E |
Casein Kinase I Isoform Gamma-3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7900 |
0.26 |
Binding ≤ 10μM
|
KIT-1-E |
Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
590 |
0.32 |
Binding ≤ 10μM
|
KKCC1-1-E |
CaM-kinase Kinase Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2900 |
0.29 |
Binding ≤ 10μM
|
KKCC2-1-E |
CaM-kinase Kinase Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2600 |
0.29 |
Binding ≤ 10μM
|
KPCD-1-E |
Protein Kinase C Delta (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
4500 |
0.28 |
Binding ≤ 10μM
|
KPCD1-1-E |
Protein Kinase C Mu (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
8400 |
0.26 |
Binding ≤ 10μM
|
KPCD3-1-E |
Protein Kinase C Nu (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4200 |
0.28 |
Binding ≤ 10μM
|
KPCT-1-E |
Protein Kinase C Theta (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4400 |
0.28 |
Binding ≤ 10μM
|
KS6A1-1-E |
Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4000 |
0.28 |
Binding ≤ 10μM
|
KS6A2-1-E |
Ribosomal Protein S6 Kinase Alpha 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
410 |
0.33 |
Binding ≤ 10μM
|
KS6A4-1-E |
Ribosomal Protein S6 Kinase Alpha 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3000 |
0.29 |
Binding ≤ 10μM
|
KSYK-1-E |
Tyrosine-protein Kinase SYK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1300 |
0.31 |
Binding ≤ 10μM
|
LIMK1-1-E |
LIM Domain Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
620 |
0.32 |
Binding ≤ 10μM
|
LIMK2-1-E |
LIM Domain Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.31 |
Binding ≤ 10μM
|
M3K9-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 9 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3600 |
0.28 |
Binding ≤ 10μM
|
M4K1-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
120 |
0.36 |
Binding ≤ 10μM
|
M4K3-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
820 |
0.32 |
Binding ≤ 10μM
|
M4K5-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2100 |
0.29 |
Binding ≤ 10μM
|
MARK1-1-E |
Serine/threonine-protein Kinase MARK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
620 |
0.32 |
Binding ≤ 10μM
|
MARK2-1-E |
MAP/microtubule Affinity-regulating Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1200 |
0.31 |
Binding ≤ 10μM
|
MARK3-1-E |
Serine/threonine-protein Kinase C-TAK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
600 |
0.32 |
Binding ≤ 10μM
|
MARK4-1-E |
MAP/microtubule Affinity-regulating Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
660 |
0.32 |
Binding ≤ 10μM
|
MERTK-1-E |
Proto-oncogene Tyrosine-protein Kinase MER (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2800 |
0.29 |
Binding ≤ 10μM
|
MET-1-E |
Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
650 |
0.32 |
Binding ≤ 10μM
|
MK04-1-E |
Mitogen-activated Protein Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1600 |
0.30 |
Binding ≤ 10μM
|
MK06-1-E |
Mitogen-activated Protein Kinase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
480 |
0.33 |
Binding ≤ 10μM
|
MK07-1-E |
Mitogen-activated Protein Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
520 |
0.33 |
Binding ≤ 10μM
|
MK08-1-E |
Mitogen-activated Protein Kinase 8 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
1700 |
0.30 |
Binding ≤ 10μM
|
MK10-1-E |
C-Jun N-terminal Kinase 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1300 |
0.31 |
Binding ≤ 10μM
|
MK15-1-E |
Mitogen-activated Protein Kinase 15 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1100 |
0.31 |
Binding ≤ 10μM
|
MP2K1-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
1800 |
0.30 |
Binding ≤ 10μM
|
MP2K2-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5600 |
0.27 |
Binding ≤ 10μM
|
MP2K3-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1500 |
0.30 |
Binding ≤ 10μM
|
MP2K4-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
630 |
0.32 |
Binding ≤ 10μM
|
MP2K6-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.31 |
Binding ≤ 10μM
|
MST4-1-E |
Serine/threonine-protein Kinase MST4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
210 |
0.35 |
Binding ≤ 10μM
|
MYLK-1-E |
Myosin Light Chain Kinase, Smooth Muscle (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2100 |
0.29 |
Binding ≤ 10μM
|
NUAK1-1-E |
NUAK Family SNF1-like Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
180 |
0.35 |
Binding ≤ 10μM
|
NUAK2-1-E |
NUAK Family SNF1-like Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
26 |
0.39 |
Binding ≤ 10μM
|
PAK3-1-E |
Serine/threonine-protein Kinase PAK 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2100 |
0.29 |
Binding ≤ 10μM
|
PAK4-1-E |
Serine/threonine-protein Kinase PAK 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2300 |
0.29 |
Binding ≤ 10μM
|
PAK6-1-E |
Serine/threonine-protein Kinase PAK6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.30 |
Binding ≤ 10μM
|
PAK7-1-E |
Serine/threonine-protein Kinase PAK7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
830 |
0.32 |
Binding ≤ 10μM
|
PDPK1-1-E |
3-phosphoinositide Dependent Protein Kinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3100 |
0.29 |
Binding ≤ 10μM
|
PGFRA-1-E |
Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4000 |
0.28 |
Binding ≤ 10μM
|
PGFRB-1-E |
Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
910 |
0.31 |
Binding ≤ 10μM
|
PI42B-1-E |
Phosphatidylinositol-5-phosphate 4-kinase Type-2 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1300 |
0.31 |
Binding ≤ 10μM
|
PI51A-1-E |
Phosphatidylinositol-4-phosphate 5-kinase Type-1 Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9200 |
0.26 |
Binding ≤ 10μM
|
PKN2-1-E |
Protein Kinase N2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1900 |
0.30 |
Binding ≤ 10μM
|
PLK1-1-E |
Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5000 |
0.27 |
Binding ≤ 10μM
|
PLK3-1-E |
Serine/threonine-protein Kinase PLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7100 |
0.27 |
Binding ≤ 10μM
|
PLK4-1-E |
Serine/threonine-protein Kinase PLK4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
120 |
0.36 |
Binding ≤ 10μM
|
RET-1-E |
Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4200 |
0.28 |
Binding ≤ 10μM
|
RIOK1-1-E |
Serine/threonine-protein Kinase RIO1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1100 |
0.31 |
Binding ≤ 10μM
|
RIOK3-1-E |
Serine/threonine-protein Kinase RIO3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1200 |
0.31 |
Binding ≤ 10μM
|
RIPK1-1-E |
Receptor-interacting Serine/threonine-protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1800 |
0.30 |
Binding ≤ 10μM
|
SIK1-1-E |
Serine/threonine-protein Kinase SIK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2200 |
0.29 |
Binding ≤ 10μM
|
SIK2-1-E |
Serine/threonine-protein Kinase SIK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1600 |
0.30 |
Binding ≤ 10μM
|
SLK-1-E |
Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
48 |
0.38 |
Binding ≤ 10μM
|
SRPK1-1-E |
Serine/threonine-protein Kinase SRPK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2800 |
0.29 |
Binding ≤ 10μM
|
ST17A-1-E |
Serine/threonine-protein Kinase 17A (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5600 |
0.27 |
Binding ≤ 10μM
|
STK10-1-E |
Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
110 |
0.36 |
Binding ≤ 10μM
|
STK16-1-E |
Serine/threonine-protein Kinase 16 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
140 |
0.36 |
Binding ≤ 10μM
|
STK24-1-E |
Serine/threonine-protein Kinase 24 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
180 |
0.35 |
Binding ≤ 10μM
|
STK25-1-E |
Serine/threonine-protein Kinase 25 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
360 |
0.33 |
Binding ≤ 10μM
|
STK3-1-E |
Serine/threonine-protein Kinase MST2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
61 |
0.37 |
Binding ≤ 10μM
|
STK4-1-E |
Serine/threonine-protein Kinase MST1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
130 |
0.36 |
Binding ≤ 10μM
|
TEC-1-E |
Tyrosine-protein Kinase TEC (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.31 |
Binding ≤ 10μM
|
TESK1-1-E |
Dual Specificity Testis-specific Protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3100 |
0.29 |
Binding ≤ 10μM
|
TIE1-1-E |
Tyrosine-protein Kinase Receptor Tie-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
260 |
0.34 |
Binding ≤ 10μM
|
TIE2-1-E |
Tyrosine-protein Kinase TIE-2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
950 |
0.31 |
Binding ≤ 10μM
|
TLK1-1-E |
Serine/threonine-protein Kinase Tousled-like 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1100 |
0.31 |
Binding ≤ 10μM
|
TLK2-1-E |
Serine/threonine-protein Kinase Tousled-like 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
750 |
0.32 |
Binding ≤ 10μM
|
TNI3K-1-E |
Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.30 |
Binding ≤ 10μM
|
TTK-1-E |
Dual Specificity Protein Kinase TTK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
190 |
0.35 |
Binding ≤ 10μM
|
TYK2-1-E |
Tyrosine-protein Kinase TYK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
32 |
0.39 |
Binding ≤ 10μM
|
UFO-1-E |
Tyrosine-protein Kinase Receptor UFO (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2200 |
0.29 |
Binding ≤ 10μM
|
VGFR1-1-E |
Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2100 |
0.29 |
Binding ≤ 10μM
|
VGFR2-1-E |
Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3700 |
0.28 |
Binding ≤ 10μM
|
VGFR3-1-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1100 |
0.31 |
Binding ≤ 10μM
|
Z104295-1-O |
Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other |
Other |
110 |
0.36 |
Binding ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
450 |
0.33 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
120 |
0.36 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
750 |
0.32 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
254 |
0.34 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
284 |
0.34 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
590 |
0.32 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.97 |
5.91 |
-18.67 |
5 |
9 |
0 |
146 |
394.363 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.99 |
4.7 |
-10.72 |
4 |
6 |
0 |
111 |
396.439 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
7090 |
0.25 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
5930 |
0.25 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.99 |
4.43 |
-11.69 |
4 |
6 |
0 |
111 |
396.439 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.49 |
4.29 |
-16.48 |
2 |
9 |
0 |
138 |
252.186 |
4 |
↓
|
|
|
Analogs
-
15449189
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50425-1-O |
Plasmodium Falciparum (cluster #1 Of 22), Other |
Other |
56 |
0.51 |
Functional ≤ 10μM
|
Z50426-3-O |
Plasmodium Falciparum (isolate K1 / Thailand) (cluster #3 Of 9), Other |
Other |
6 |
0.58 |
Functional ≤ 10μM
|
Z50436-3-O |
Filobasidiella Neoformans (cluster #3 Of 3), Other |
Other |
280 |
0.46 |
Functional ≤ 10μM
|
Z50442-2-O |
Candida Albicans (cluster #2 Of 4), Other |
Other |
880 |
0.42 |
Functional ≤ 10μM
|
Z80156-3-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #3 Of 12), Other |
Other |
2900 |
0.39 |
Functional ≤ 10μM
|
Z80482-1-O |
SK-MEL-2 (Melanoma Cells) (cluster #1 Of 4), Other |
Other |
750 |
0.43 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
850 |
0.42 |
Functional ≤ 10μM
|
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
540 |
0.44 |
Functional ≤ 10μM
|
Z80682-6-O |
A549 (Lung Carcinoma Cells) (cluster #6 Of 11), Other |
Other |
630 |
0.43 |
Functional ≤ 10μM
|
Z81057-2-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #2 Of 4), Other |
Other |
8910 |
0.35 |
Functional ≤ 10μM
|
Z81072-2-O |
Jurkat (Acute Leukemic T-cells) (cluster #2 Of 10), Other |
Other |
650 |
0.43 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
460 |
0.44 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.78 |
3.29 |
-6.48 |
1 |
5 |
0 |
57 |
284.352 |
0 |
↓
|
|
|
Analogs
-
15449187
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50425-1-O |
Plasmodium Falciparum (cluster #1 Of 22), Other |
Other |
56 |
0.51 |
Functional ≤ 10μM
|
Z50426-3-O |
Plasmodium Falciparum (isolate K1 / Thailand) (cluster #3 Of 9), Other |
Other |
6 |
0.58 |
Functional ≤ 10μM
|
Z50436-3-O |
Filobasidiella Neoformans (cluster #3 Of 3), Other |
Other |
280 |
0.46 |
Functional ≤ 10μM
|
Z50442-2-O |
Candida Albicans (cluster #2 Of 4), Other |
Other |
880 |
0.42 |
Functional ≤ 10μM
|
Z80156-3-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #3 Of 12), Other |
Other |
2900 |
0.39 |
Functional ≤ 10μM
|
Z80482-1-O |
SK-MEL-2 (Melanoma Cells) (cluster #1 Of 4), Other |
Other |
750 |
0.43 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
850 |
0.42 |
Functional ≤ 10μM
|
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
540 |
0.44 |
Functional ≤ 10μM
|
Z80682-6-O |
A549 (Lung Carcinoma Cells) (cluster #6 Of 11), Other |
Other |
630 |
0.43 |
Functional ≤ 10μM
|
Z81057-2-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #2 Of 4), Other |
Other |
8910 |
0.35 |
Functional ≤ 10μM
|
Z81072-2-O |
Jurkat (Acute Leukemic T-cells) (cluster #2 Of 10), Other |
Other |
650 |
0.43 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
460 |
0.44 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.78 |
3.66 |
-6.09 |
1 |
5 |
0 |
57 |
284.352 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ABL1-1-E |
Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
820 |
0.25 |
Binding ≤ 10μM
|
ABL2-1-E |
Tyrosine-protein Kinase ABL2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3300 |
0.23 |
Binding ≤ 10μM
|
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4 |
0.35 |
Binding ≤ 10μM
|
AURKB-1-E |
Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
9 |
0.33 |
Binding ≤ 10μM
|
AURKC-1-E |
Serine/threonine-protein Kinase Aurora-C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
26 |
0.31 |
Binding ≤ 10μM
|
BLK-1-E |
Tyrosine-protein Kinase BLK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
68 |
0.30 |
Binding ≤ 10μM
|
BMX-1-E |
Tyrosine-protein Kinase BMX (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3100 |
0.23 |
Binding ≤ 10μM
|
BTK-1-E |
Tyrosine-protein Kinase BTK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4200 |
0.22 |
Binding ≤ 10μM
|
CLK2-1-E |
Dual Specificity Protein Kinase CLK2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3200 |
0.23 |
Binding ≤ 10μM
|
CLK3-1-E |
Dual Specificity Protein Kinase CLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2300 |
0.23 |
Binding ≤ 10μM
|
CSK-1-E |
Tyrosine-protein Kinase CSK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9000 |
0.21 |
Binding ≤ 10μM
|
DDR1-1-E |
Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4200 |
0.22 |
Binding ≤ 10μM
|
EGFR-1-E |
Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
6400 |
0.21 |
Binding ≤ 10μM
|
EPHA1-1-E |
Ephrin Type-A Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1800 |
0.24 |
Binding ≤ 10μM
|
EPHA2-1-E |
Ephrin Type-A Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
370 |
0.26 |
Binding ≤ 10μM
|
EPHA3-1-E |
Ephrin Type-A Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2100 |
0.23 |
Binding ≤ 10μM
|
EPHA4-1-E |
Ephrin Type-A Receptor 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
420 |
0.26 |
Binding ≤ 10μM
|
EPHA5-1-E |
Ephrin Type-A Receptor 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.24 |
Binding ≤ 10μM
|
EPHA6-1-E |
Ephrin Type-A Receptor 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
580 |
0.26 |
Binding ≤ 10μM
|
EPHA7-1-E |
Ephrin Type-A Receptor 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.25 |
Binding ≤ 10μM
|
EPHB1-1-E |
Ephrin Type-B Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
330 |
0.27 |
Binding ≤ 10μM
|
EPHB3-1-E |
Ephrin Type-B Receptor 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3500 |
0.22 |
Binding ≤ 10μM
|
EPHB4-1-E |
Ephrin Type-B Receptor 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
560 |
0.26 |
Binding ≤ 10μM
|
FAK2-1-E |
Protein-tyrosine Kinase 2-beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2000 |
0.23 |
Binding ≤ 10μM
|
FER-1-E |
Tyrosine-protein Kinase FER (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4400 |
0.22 |
Binding ≤ 10μM
|
FGFR1-1-E |
Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2400 |
0.23 |
Binding ≤ 10μM
|
FGFR2-1-E |
Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1700 |
0.24 |
Binding ≤ 10μM
|
FGFR3-1-E |
Fibroblast Growth Factor Receptor 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1300 |
0.24 |
Binding ≤ 10μM
|
FGR-1-E |
Tyrosine-protein Kinase FGR (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
220 |
0.27 |
Binding ≤ 10μM
|
FYN-1-E |
Tyrosine-protein Kinase FYN (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
1300 |
0.24 |
Binding ≤ 10μM
|
HCK-1-E |
Tyrosine-protein Kinase HCK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1500 |
0.24 |
Binding ≤ 10μM
|
IRAK3-1-E |
Interleukin-1 Receptor-associated Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.24 |
Binding ≤ 10μM
|
LCK-1-E |
Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
590 |
0.26 |
Binding ≤ 10μM
|
LYN-1-E |
Tyrosine-protein Kinase Lyn (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.24 |
Binding ≤ 10μM
|
MAPK5-1-E |
MAP Kinase-activated Protein Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.33 |
Binding ≤ 10μM
|
MERTK-1-E |
Proto-oncogene Tyrosine-protein Kinase MER (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
730 |
0.25 |
Binding ≤ 10μM
|
PLK4-1-E |
Serine/threonine-protein Kinase PLK4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
410 |
0.26 |
Binding ≤ 10μM
|
ROS1-1-E |
Proto-oncogene Tyrosine-protein Kinase ROS (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3100 |
0.23 |
Binding ≤ 10μM
|
SIK1-1-E |
Serine/threonine-protein Kinase SIK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1700 |
0.24 |
Binding ≤ 10μM
|
SRC-1-E |
Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
800 |
0.25 |
Binding ≤ 10μM
|
ST17A-1-E |
Serine/threonine-protein Kinase 17A (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
190 |
0.28 |
Binding ≤ 10μM
|
ST17B-1-E |
Serine/threonine-protein Kinase 17B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.33 |
Binding ≤ 10μM
|
STK10-1-E |
Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3700 |
0.22 |
Binding ≤ 10μM
|
TEC-1-E |
Tyrosine-protein Kinase TEC (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
730 |
0.25 |
Binding ≤ 10μM
|
TIE1-1-E |
Tyrosine-protein Kinase Receptor Tie-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1600 |
0.24 |
Binding ≤ 10μM
|
TIE2-1-E |
Tyrosine-protein Kinase TIE-2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
300 |
0.27 |
Binding ≤ 10μM
|
TNK1-1-E |
Non-receptor Tyrosine-protein Kinase TNK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2400 |
0.23 |
Binding ≤ 10μM
|
TYRO3-1-E |
Tyrosine-protein Kinase Receptor TYRO3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3100 |
0.23 |
Binding ≤ 10μM
|
UFO-1-E |
Tyrosine-protein Kinase Receptor UFO (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
440 |
0.26 |
Binding ≤ 10μM
|
VGFR1-1-E |
Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.25 |
Binding ≤ 10μM
|
VGFR3-1-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3100 |
0.23 |
Binding ≤ 10μM
|
YES-1-E |
Tyrosine-protein Kinase YES (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
260 |
0.27 |
Binding ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
150 |
0.28 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
670 |
0.25 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
790 |
0.25 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
530 |
0.26 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
860 |
0.25 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
180 |
0.28 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.27 |
12.65 |
-57.45 |
1 |
6 |
-1 |
90 |
475.862 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 29 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.30 |
8.49 |
-20.4 |
4 |
3 |
1 |
56 |
314.412 |
2 |
↓
|
|
|
Analogs
-
3996018
-
-
5855431
-
-
6482664
-
-
22062280
-
-
34019293
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 11 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4700 |
0.34 |
Binding ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4700 |
0.34 |
Binding ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4700 |
0.34 |
Binding ≤ 10μM
|
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3100 |
0.35 |
Functional ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3100 |
0.35 |
Functional ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5300 |
0.34 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
900 |
0.38 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
842 |
0.39 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
2650 |
0.35 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
867 |
0.39 |
Functional ≤ 10μM
|
Z81057-2-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #2 Of 4), Other |
Other |
840 |
0.39 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
500 |
0.40 |
Functional ≤ 10μM
|
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
1000 |
0.38 |
Functional ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
608 |
0.40 |
Functional ≤ 10μM
|
Z81252-4-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #4 Of 11), Other |
Other |
790 |
0.39 |
Functional ≤ 10μM
|
Z81057-2-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #2 Of 5), Other |
Other |
840 |
0.39 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.25 |
4.79 |
-6.89 |
2 |
3 |
0 |
50 |
302.414 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.44 |
6.68 |
-52.29 |
2 |
10 |
1 |
108 |
519.578 |
3 |
↓
|
Mid
Mid (pH 6-8)
|
1.44 |
6.56 |
-57.91 |
2 |
10 |
1 |
108 |
519.578 |
3 |
↓
|
Mid
Mid (pH 6-8)
|
1.44 |
4.21 |
-14.26 |
1 |
10 |
0 |
106 |
518.57 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 4 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80021-2-O |
A498 (Renal Carcinoma Cells) (cluster #2 Of 5), Other |
Other |
6800 |
0.28 |
Functional ≤ 10μM
|
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
2300 |
0.30 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
4500 |
0.29 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
9500 |
0.27 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
4500 |
0.29 |
Functional ≤ 10μM
|
Z80502-1-O |
SNB-78 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
9100 |
0.27 |
Functional ≤ 10μM
|
Z80514-1-O |
St-4 (Stomach Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
5000 |
0.29 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
8300 |
0.27 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
3000 |
0.30 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
2100 |
0.31 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
1100 |
0.32 |
Functional ≤ 10μM
|
Z81248-1-O |
Malme-3M (Melanoma Cells) (cluster #1 Of 3), Other |
Other |
4300 |
0.29 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
4400 |
0.29 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
2600 |
0.30 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.43 |
11.99 |
-14.17 |
1 |
4 |
0 |
59 |
390.574 |
11 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.85 |
0.85 |
-62.78 |
3 |
8 |
1 |
94 |
564.662 |
8 |
↓
|
|
|
Analogs
-
16442655
-
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.59 |
11.94 |
-91.34 |
4 |
8 |
2 |
101 |
490.604 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.55 |
5.38 |
-39.46 |
1 |
1 |
1 |
4 |
157.064 |
4 |
↓
|
|
|
Analogs
-
3977873
-
-
3977874
-
-
3977875
-
-
4245621
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CASP3-1-E |
Caspase-3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.20 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
810 |
0.20 |
Binding ≤ 10μM |
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
810 |
0.20 |
Binding ≤ 10μM |
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.25 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.25 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.25 |
Functional ≤ 10μM
|
Z100733-1-O |
CT26 (Colon Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
200 |
0.22 |
Functional ≤ 10μM
|
Z100752-1-O |
Renca (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2900 |
0.18 |
Functional ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
3920 |
0.18 |
Functional ≤ 10μM
|
Z103204-2-O |
A427 (cluster #2 Of 4), Other |
Other |
130 |
0.23 |
Functional ≤ 10μM
|
Z103413-1-O |
SW948 (cluster #1 Of 1), Other |
Other |
1300 |
0.20 |
Functional ≤ 10μM
|
Z50425-1-O |
Plasmodium Falciparum (cluster #1 Of 22), Other |
Other |
5012 |
0.18 |
Functional ≤ 10μM
|
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
990 |
0.20 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
530 |
0.21 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
2150 |
0.19 |
Functional ≤ 10μM
|
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
360 |
0.21 |
Functional ≤ 10μM |
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
9000 |
0.17 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
2 |
0.29 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
1200 |
0.20 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
100 |
0.23 |
Functional ≤ 10μM
|
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
350 |
0.22 |
Functional ≤ 10μM
|
Z80112-1-O |
DAN-G (cluster #1 Of 2), Other |
Other |
380 |
0.21 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
5160 |
0.18 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
970 |
0.20 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
750 |
0.20 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
6600 |
0.17 |
Functional ≤ 10μM
|
Z80179-1-O |
J82 (Bladder Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
800 |
0.20 |
Functional ≤ 10μM |
Z80186-9-O |
K562 (Erythroleukemia Cells) (cluster #9 Of 11), Other |
Other |
522 |
0.21 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
567 |
0.21 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
834 |
0.20 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
2300 |
0.19 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
878 |
0.20 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
600 |
0.21 |
Functional ≤ 10μM
|
Z80284-3-O |
MOLT-3 (T-lymphoblastic Leukemia Cells) (cluster #3 Of 3), Other |
Other |
65 |
0.24 |
Functional ≤ 10μM
|
Z80285-1-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #1 Of 4), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM |
Z80288-1-O |
MOVP-3 (cluster #1 Of 1), Other |
Other |
7550 |
0.17 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
1250 |
0.20 |
Functional ≤ 10μM
|
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
1500 |
0.19 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
50 |
0.24 |
Functional ≤ 10μM
|
Z80390-2-O |
PC-3 (Prostate Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
7800 |
0.17 |
Functional ≤ 10μM
|
Z80435-1-O |
RT-112 (cluster #1 Of 1), Other |
Other |
220 |
0.22 |
Functional ≤ 10μM
|
Z80436-1-O |
RT-4 (cluster #1 Of 1), Other |
Other |
1330 |
0.20 |
Functional ≤ 10μM
|
Z80473-1-O |
SISO (cluster #1 Of 2), Other |
Other |
150 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
300 |
0.22 |
Functional ≤ 10μM
|
Z80482-1-O |
SK-MEL-2 (Melanoma Cells) (cluster #1 Of 4), Other |
Other |
5720 |
0.17 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
850 |
0.20 |
Functional ≤ 10μM
|
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
2500 |
0.19 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
275 |
0.22 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
4900 |
0.18 |
Functional ≤ 10μM
|
Z80546-1-O |
TERT-RPE1 (Retinal Pigmented Epithelial Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.23 |
Functional ≤ 10μM
|
Z80548-4-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #4 Of 5), Other |
Other |
2160 |
0.19 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
500 |
0.21 |
Functional ≤ 10μM
|
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
3480 |
0.18 |
Functional ≤ 10μM
|
Z80601-1-O |
XRS6 (cluster #1 Of 1), Other |
Other |
140 |
0.23 |
Functional ≤ 10μM
|
Z80604-1-O |
YAPC (cluster #1 Of 2), Other |
Other |
1320 |
0.20 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
240 |
0.22 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
9980 |
0.17 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
160 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
3667 |
0.18 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
740 |
0.20 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
591 |
0.21 |
Functional ≤ 10μM
|
Z80866-1-O |
GLC4 Cell Line (cluster #1 Of 1), Other |
Other |
820 |
0.20 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
1590 |
0.19 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
1192 |
0.20 |
Functional ≤ 10μM
|
Z80901-1-O |
HaCaT (Keratinocytes) (cluster #1 Of 2), Other |
Other |
550 |
0.21 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
9500 |
0.17 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
4900 |
0.18 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
90 |
0.23 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
500 |
0.21 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
3250 |
0.18 |
Functional ≤ 10μM
|
Z81065-1-O |
IGROV-1 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
985 |
0.20 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
160 |
0.23 |
Functional ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
800 |
0.20 |
Functional ≤ 10μM
|
Z81126-1-O |
KYSE-150 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.21 |
Functional ≤ 10μM
|
Z81128-1-O |
KYSE-520 Cell Line (cluster #1 Of 1), Other |
Other |
410 |
0.21 |
Functional ≤ 10μM
|
Z81130-1-O |
KYSE-70 Cell Line (cluster #1 Of 1), Other |
Other |
790 |
0.20 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
180 |
0.22 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
577 |
0.21 |
Functional ≤ 10μM |
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
8930 |
0.17 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
700 |
0.21 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
240 |
0.22 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
80 |
0.24 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
900 |
0.20 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.22 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
3930 |
0.18 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.70 |
-7.49 |
-18.52 |
3 |
13 |
0 |
160 |
588.562 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 90 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.72 |
1.27 |
-49.96 |
4 |
3 |
1 |
56 |
148.189 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.64 |
7.48 |
-8.03 |
3 |
5 |
0 |
75 |
320.396 |
4 |
↓
|
|
|
Analogs
-
60292553
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
PGH2-7-E |
Cyclooxygenase-2 (cluster #7 Of 8), Eukaryotic |
Eukaryotes |
40 |
0.40 |
Binding ≤ 10μM
|
Z80125-2-O |
DU-145 (Prostate Carcinoma) (cluster #2 Of 9), Other |
Other |
24 |
0.41 |
Functional ≤ 10μM
|
Z80166-2-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #2 Of 12), Other |
Other |
2 |
0.47 |
Functional ≤ 10μM
|
Z80186-4-O |
K562 (Erythroleukemia Cells) (cluster #4 Of 11), Other |
Other |
50 |
0.39 |
Functional ≤ 10μM
|
Z80224-2-O |
MCF7 (Breast Carcinoma Cells) (cluster #2 Of 14), Other |
Other |
19 |
0.42 |
Functional ≤ 10μM
|
Z80244-3-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #3 Of 7), Other |
Other |
10 |
0.43 |
Functional ≤ 10μM
|
Z80390-2-O |
PC-3 (Prostate Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
43 |
0.40 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
9 |
0.43 |
Functional ≤ 10μM
|
Z80559-2-O |
U251 (cluster #2 Of 3), Other |
Other |
49 |
0.39 |
Functional ≤ 10μM
|
Z80682-3-O |
A549 (Lung Carcinoma Cells) (cluster #3 Of 11), Other |
Other |
59 |
0.39 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
10 |
0.43 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
43 |
0.40 |
Functional ≤ 10μM
|
Z81247-3-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #3 Of 9), Other |
Other |
47 |
0.39 |
Functional ≤ 10μM
|
Z81252-4-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #4 Of 11), Other |
Other |
24 |
0.41 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
29 |
0.41 |
Functional ≤ 10μM
|
Z80253-2-O |
MEF (Embryonic Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
9200 |
0.27 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.57 |
-5.07 |
-17.26 |
1 |
6 |
0 |
84 |
360.406 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Popular Name:
(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione
(1aR,8S,13S,14S,15aR)-5,13,14-tr…
Find On:
PubMed —
Wikipedia —
Google
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
5900 |
0.27 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
70 |
0.37 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.62 |
-1.34 |
-13 |
3 |
8 |
0 |
126 |
378.377 |
1 |
↓
|
Ref
Reference (pH 7)
|
0.62 |
-0.29 |
-13.1 |
3 |
8 |
0 |
126 |
378.377 |
1 |
↓
|
Hi
High (pH 8-9.5)
|
0.62 |
-0.33 |
-38.75 |
2 |
8 |
-1 |
129 |
377.369 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.47 |
7.75 |
-72.23 |
1 |
8 |
0 |
109 |
451.57 |
12 |
↓
|
Mid
Mid (pH 6-8)
|
2.47 |
8.22 |
-51.43 |
2 |
8 |
1 |
107 |
452.578 |
12 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 14 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.47 |
10.69 |
-11.53 |
1 |
5 |
0 |
64 |
389.842 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.55 |
7.48 |
-9.5 |
2 |
2 |
0 |
39 |
220.275 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
EGFR-1-E |
Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
9 |
0.28 |
Binding ≤ 10μM
|
ERBB2-2-E |
Receptor Protein-tyrosine Kinase ErbB-2 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
9 |
0.28 |
Binding ≤ 10μM
|
PGFRB-1-E |
Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8500 |
0.18 |
Binding ≤ 10μM
|
RIPK2-1-E |
Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3600 |
0.19 |
Binding ≤ 10μM
|
SLK-1-E |
Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
9300 |
0.18 |
Binding ≤ 10μM
|
STK10-1-E |
Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4400 |
0.19 |
Binding ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
54 |
0.25 |
Binding ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
970 |
0.21 |
Functional ≤ 10μM
|
Z80046-1-O |
BT-474 (Breast Ductal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
6600 |
0.18 |
Functional ≤ 10μM
|
Z80300-1-O |
N87 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z80475-3-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #3 Of 3), Other |
Other |
4350 |
0.19 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
3 |
0.30 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
8500 |
0.18 |
Functional ≤ 10μM
|
Z80954-1-O |
HFF (Foreskin Fibroblasts) (cluster #1 Of 4), Other |
Other |
9900 |
0.18 |
Functional ≤ 10μM
|
Z80961-1-O |
HN5 (Squamous Cell Carcinoma) (cluster #1 Of 1), Other |
Other |
25 |
0.27 |
Functional ≤ 10μM
|
Z81020-7-O |
HepG2 (Hepatoblastoma Cells) (cluster #7 Of 8), Other |
Other |
6270 |
0.18 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
5900 |
0.18 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
5400 |
0.18 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.16 |
-3.53 |
-72.53 |
3 |
8 |
1 |
110 |
582.077 |
11 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
7.79 |
2.33 |
-65.86 |
1 |
8 |
-1 |
122 |
627.754 |
8 |
↓
|
|
|
Analogs
-
43427402
-
-
8214360
-
-
8214363
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.40 |
5.25 |
-6.37 |
0 |
5 |
0 |
46 |
298.379 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 36 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5300 |
0.23 |
Binding ≤ 10μM
|
Z100250-1-O |
Calf Thymus DNA (cluster #1 Of 2), Other |
Other |
400 |
0.28 |
Binding ≤ 10μM
|
Z50380-1-O |
Mycobacterium Smegmatis (cluster #1 Of 4), Other |
Other |
9700 |
0.22 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
1259 |
0.26 |
Functional ≤ 10μM
|
Z50587-1-O |
Homo Sapiens (cluster #1 Of 9), Other |
Other |
10 |
0.35 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
26 |
0.33 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
3600 |
0.24 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6 |
0.36 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1 |
0.39 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
8200 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
66 |
0.31 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
8700 |
0.22 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
7 |
0.36 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
10 |
0.35 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
10 |
0.35 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
9 |
0.35 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
30 |
0.33 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
28 |
0.33 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
12 |
0.35 |
Functional ≤ 10μM
|
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6 |
0.36 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
4 |
0.37 |
Functional ≤ 10μM
|
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
395 |
0.28 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
7 |
0.36 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.33 |
Functional ≤ 10μM
|
Z80463-1-O |
SCOV-3 (cluster #1 Of 1), Other |
Other |
5 |
0.36 |
Functional ≤ 10μM |
Z80475-2-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #2 Of 3), Other |
Other |
16 |
0.34 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
9800 |
0.22 |
Functional ≤ 10μM
|
Z80601-1-O |
XRS6 (cluster #1 Of 1), Other |
Other |
10 |
0.35 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
8000 |
0.22 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
3 |
0.37 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
7200 |
0.22 |
Functional ≤ 10μM
|
Z81017-2-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
8 |
0.35 |
Functional ≤ 10μM
|
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
6 |
0.36 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
20 |
0.34 |
Functional ≤ 10μM
|
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
646 |
0.27 |
Functional ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
100 |
0.31 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
960 |
0.26 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
48 |
0.32 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
27 |
0.33 |
Functional ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
8000 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.36 |
-2.16 |
-97.76 |
10 |
10 |
2 |
172 |
446.504 |
12 |
↓
|
Hi
High (pH 8-9.5)
|
0.36 |
-3.57 |
-51.37 |
9 |
10 |
1 |
168 |
445.496 |
12 |
↓
|
|
|
Analogs
-
33822027
-
-
33822028
-
-
1087
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 55 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TOP1-1-E |
DNA Topoisomerase 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1600 |
0.31 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
9000 |
0.27 |
Binding ≤ 10μM
|
CHK1-1-E |
Serine/threonine-protein Kinase Chk1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.47 |
Functional ≤ 10μM
|
SSR1-1-E |
Somatostatin Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.47 |
Functional ≤ 10μM
|
SSR2-1-E |
Somatostatin Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.47 |
Functional ≤ 10μM
|
SSR3-1-E |
Somatostatin Receptor 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.47 |
Functional ≤ 10μM
|
SSR4-1-E |
Somatostatin Receptor 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.47 |
Functional ≤ 10μM
|
SSR5-1-E |
Somatostatin Receptor 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.47 |
Functional ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
33 |
0.40 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
33 |
0.40 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
33 |
0.40 |
Functional ≤ 10μM
|
Z100501-1-O |
Lu1 (Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
29 |
0.41 |
Functional ≤ 10μM
|
Z100733-1-O |
CT26 (Colon Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
34 |
0.40 |
Functional ≤ 10μM
|
Z100752-1-O |
Renca (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
304 |
0.35 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
11 |
0.43 |
Functional ≤ 10μM
|
Z103408-1-O |
SW626 (cluster #1 Of 2), Other |
Other |
29 |
0.41 |
Functional ≤ 10μM
|
Z103413-1-O |
SW948 (cluster #1 Of 1), Other |
Other |
160 |
0.37 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
794 |
0.33 |
Functional ≤ 10μM
|
Z80012-1-O |
A 172 (Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
29 |
0.41 |
Functional ≤ 10μM
|
Z80012-1-O |
A 172 (Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
140 |
0.37 |
Functional ≤ 10μM |
Z80019-1-O |
A-427 (Lung Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
24 |
0.41 |
Functional ≤ 10μM
|
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
20 |
0.41 |
Functional ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
9550 |
0.27 |
Functional ≤ 10μM |
Z80056-1-O |
CAKI-2 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
3960 |
0.29 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
5300 |
0.28 |
Functional ≤ 10μM
|
Z80068-3-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #3 Of 5), Other |
Other |
3 |
0.46 |
Functional ≤ 10μM
|
Z80099-1-O |
COLO 205 (Colon Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
5 |
0.45 |
Functional ≤ 10μM
|
Z80115-1-O |
DC3F (cluster #1 Of 1), Other |
Other |
6 |
0.44 |
Functional ≤ 10μM |
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
102 |
0.38 |
Functional ≤ 10μM
|
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
210 |
0.36 |
Functional ≤ 10μM |
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
940 |
0.32 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
1 |
0.48 |
Functional ≤ 10μM
|
Z80152-1-O |
HCT-8 (Ileocecal Adenocarcinoma) (cluster #1 Of 2), Other |
Other |
7 |
0.44 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
89 |
0.38 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.38 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
90 |
0.38 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
80 |
0.38 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
20 |
0.41 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
35 |
0.40 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
60 |
0.39 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
3100 |
0.30 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
7420 |
0.28 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
17 |
0.42 |
Functional ≤ 10μM
|
Z80295-2-O |
MT4 (Lymphocytes) (cluster #2 Of 8), Other |
Other |
4 |
0.45 |
Functional ≤ 10μM
|
Z80316-1-O |
NCI-H128 (cluster #1 Of 1), Other |
Other |
18 |
0.42 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
9 |
0.43 |
Functional ≤ 10μM
|
Z80372-1-O |
P388CPT5 (cluster #1 Of 1), Other |
Other |
2800 |
0.30 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
57 |
0.39 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.32 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
40 |
0.40 |
Functional ≤ 10μM |
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
20 |
0.41 |
Functional ≤ 10μM
|
Z80482-2-O |
SK-MEL-2 (Melanoma Cells) (cluster #2 Of 4), Other |
Other |
7860 |
0.27 |
Functional ≤ 10μM |
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
40 |
0.40 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
51 |
0.39 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
53 |
0.39 |
Functional ≤ 10μM
|
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
88 |
0.38 |
Functional ≤ 10μM
|
Z80548-1-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
600 |
0.34 |
Functional ≤ 10μM
|
Z80623-1-O |
Panel (56 Tumour Cell Lines) (cluster #1 Of 1), Other |
Other |
40 |
0.40 |
Functional ≤ 10μM
|
Z80647-1-O |
833K Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.43 |
Functional ≤ 10μM |
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
91 |
0.38 |
Functional ≤ 10μM |
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
7 |
0.44 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
207 |
0.36 |
Functional ≤ 10μM
|
Z80751-1-O |
Caov-3 Cell Line (cluster #1 Of 1), Other |
Other |
30 |
0.41 |
Functional ≤ 10μM |
Z80751-1-O |
Caov-3 Cell Line (cluster #1 Of 1), Other |
Other |
32 |
0.40 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
45 |
0.40 |
Functional ≤ 10μM
|
Z80799-1-O |
RPMI 8402 (Pre-T-lymphoblastoid Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.44 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
1 |
0.48 |
Functional ≤ 10μM
|
Z80898-1-O |
NCI-H928 (cluster #1 Of 1), Other |
Other |
8 |
0.44 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
9 |
0.43 |
Functional ≤ 10μM
|
Z80930-1-O |
HEC-1B Cell Line (cluster #1 Of 1), Other |
Other |
60 |
0.39 |
Functional ≤ 10μM
|
Z80930-1-O |
HEC-1B Cell Line (cluster #1 Of 1), Other |
Other |
8640 |
0.27 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
17 |
0.42 |
Functional ≤ 10μM
|
Z81020-7-O |
HepG2 (Hepatoblastoma Cells) (cluster #7 Of 8), Other |
Other |
60 |
0.39 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
330 |
0.35 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
7 |
0.44 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
59 |
0.39 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
6 |
0.44 |
Functional ≤ 10μM
|
Z81080-1-O |
KATO-III Cell Line (cluster #1 Of 1), Other |
Other |
448 |
0.34 |
Functional ≤ 10μM
|
Z81080-1-O |
KATO-III Cell Line (cluster #1 Of 1), Other |
Other |
1170 |
0.32 |
Functional ≤ 10μM |
Z81084-1-O |
KB VCR R (cluster #1 Of 1), Other |
Other |
9 |
0.43 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
9 |
0.43 |
Functional ≤ 10μM
|
Z81134-1-O |
L2987 (Lung Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
400 |
0.34 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
33 |
0.40 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
33 |
0.40 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
86 |
0.38 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
48 |
0.39 |
Functional ≤ 10μM
|
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
710 |
0.33 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
940 |
0.32 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
970 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
2 |
0.47 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
83 |
0.38 |
Functional ≤ 10μM
|
Z80291-2-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #2 Of 3), Other |
Other |
890 |
0.33 |
ADME/T ≤ 10μM |
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
500 |
0.34 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.03 |
6.76 |
-12.81 |
1 |
6 |
0 |
81 |
348.358 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 25 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1700 |
0.35 |
Binding ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1700 |
0.35 |
Binding ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
530 |
0.38 |
Binding ≤ 10μM
|
TBA4A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
30 |
0.46 |
Binding ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
530 |
0.38 |
Binding ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2900 |
0.34 |
Binding ≤ 10μM |
Q25270-2-E |
Beta Tubulin (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2000 |
0.35 |
Functional ≤ 10μM
|
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
660 |
0.38 |
Functional ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
660 |
0.38 |
Functional ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
530 |
0.38 |
Functional ≤ 10μM
|
TBA4A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4920 |
0.32 |
Functional ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
530 |
0.38 |
Functional ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
660 |
0.38 |
Functional ≤ 10μM
|
TBB3-3-E |
Tubulin Beta-3 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
TBB4A-3-E |
Tubulin Beta-4 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
TBB4B-3-E |
Tubulin Beta-2 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
TBB5-1-E |
Tubulin Beta-5 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
TBB8-3-E |
Tubulin Beta-8 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
Z100495-1-O |
BMEC (Brain Microvessel Endothelial Cells) (cluster #1 Of 1), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z100742-1-O |
MeWo (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM |
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
188 |
0.41 |
Functional ≤ 10μM |
Z103208-1-O |
AU565 (cluster #1 Of 1), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM |
Z103407-2-O |
SW1990 (cluster #2 Of 2), Other |
Other |
250 |
0.40 |
Functional ≤ 10μM
|
Z50591-2-O |
Bos Taurus (cluster #2 Of 2), Other |
Other |
2000 |
0.35 |
Functional ≤ 10μM
|
Z50594-1-O |
Mus Musculus (cluster #1 Of 9), Other |
Other |
18 |
0.47 |
Functional ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z80013-2-O |
A10 (cluster #2 Of 2), Other |
Other |
7 |
0.50 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80035-5-O |
B16 (Melanoma Cells) (cluster #5 Of 7), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM
|
Z80064-4-O |
CCRF-CEM (T-cell Leukemia) (cluster #4 Of 9), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80071-2-O |
CEM-0 (T-cell Leukemia) (cluster #2 Of 2), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80099-3-O |
COLO 205 (Colon Adenocarcinoma Cells) (cluster #3 Of 3), Other |
Other |
2756 |
0.34 |
Functional ≤ 10μM
|
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
36 |
0.45 |
Functional ≤ 10μM
|
Z80121-1-O |
DMS-79 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
124 |
0.42 |
Functional ≤ 10μM
|
Z80125-9-O |
DU-145 (Prostate Carcinoma) (cluster #9 Of 9), Other |
Other |
9 |
0.49 |
Functional ≤ 10μM
|
Z80136-2-O |
FM3A (Breast Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
42 |
0.45 |
Functional ≤ 10μM |
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
94 |
0.43 |
Functional ≤ 10μM |
Z80186-6-O |
K562 (Erythroleukemia Cells) (cluster #6 Of 11), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM |
Z80193-1-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #1 Of 12), Other |
Other |
8 |
0.49 |
Functional ≤ 10μM
|
Z80211-2-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM |
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
8 |
0.49 |
Functional ≤ 10μM
|
Z80229-1-O |
MCF7-DOX (Breast Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
13 |
0.48 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
82 |
0.43 |
Functional ≤ 10μM
|
Z80284-3-O |
MOLT-3 (T-lymphoblastic Leukemia Cells) (cluster #3 Of 3), Other |
Other |
9 |
0.49 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
16 |
0.47 |
Functional ≤ 10μM
|
Z80353-1-O |
OVCAR (cluster #1 Of 1), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
5400 |
0.32 |
Functional ≤ 10μM
|
Z80471-3-O |
SH-SY5 (Bone Marrow Neuroblastoma Cells) (cluster #3 Of 3), Other |
Other |
6 |
0.50 |
Functional ≤ 10μM
|
Z80485-3-O |
SK-MEL-28 (Melanoma Cells) (cluster #3 Of 6), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
6 |
0.50 |
Functional ≤ 10μM |
Z80555-1-O |
TSGH (cluster #1 Of 1), Other |
Other |
45 |
0.45 |
Functional ≤ 10μM
|
Z80682-7-O |
A549 (Lung Carcinoma Cells) (cluster #7 Of 11), Other |
Other |
8 |
0.49 |
Functional ≤ 10μM
|
Z80697-3-O |
Bel-7402 (Hepatoma Cells) (cluster #3 Of 3), Other |
Other |
10 |
0.49 |
Functional ≤ 10μM
|
Z80711-1-O |
NCI/ADR-RES (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80792-1-O |
Colon 26 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
9 |
0.49 |
Functional ≤ 10μM
|
Z80798-1-O |
CPT30 Cell Line (cluster #1 Of 1), Other |
Other |
7 |
0.50 |
Functional ≤ 10μM
|
Z80847-3-O |
FaDu (Pharyngeal Carcinoma Cells) (cluster #3 Of 3), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80852-2-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z80874-2-O |
CEM (T-cell Leukemia) (cluster #2 Of 7), Other |
Other |
12 |
0.48 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80900-1-O |
HA22T Cell Line (cluster #1 Of 1), Other |
Other |
2708 |
0.34 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
6 |
0.50 |
Functional ≤ 10μM
|
Z80967-2-O |
Hone-1 Cell Line (cluster #2 Of 2), Other |
Other |
7 |
0.50 |
Functional ≤ 10μM
|
Z81001-1-O |
TSGH 9201 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
38 |
0.45 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
6 |
0.50 |
Functional ≤ 10μM
|
Z81024-5-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #5 Of 8), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z81057-1-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #1 Of 4), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM
|
Z81065-3-O |
IGROV-1 (Ovarian Adenocarcinoma Cells) (cluster #3 Of 3), Other |
Other |
10 |
0.49 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM |
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
10 |
0.49 |
Functional ≤ 10μM
|
Z81233-2-O |
M21 (Melanoma Cells) (cluster #2 Of 2), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM |
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM |
Z81252-7-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #7 Of 11), Other |
Other |
43 |
0.45 |
Functional ≤ 10μM |
Z81331-6-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #6 Of 6), Other |
Other |
23 |
0.46 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z100495-1-O |
BMEC (Brain Microvessel Endothelial Cells) (cluster #1 Of 1), Other |
Other |
4 |
0.51 |
ADME/T ≤ 10μM
|
Z80013-2-O |
A10 (cluster #2 Of 2), Other |
Other |
23 |
0.46 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
3 |
0.52 |
ADME/T ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
0 |
0.00 |
ADME/T ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 4), Other |
Other |
2 |
0.53 |
ADME/T ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
0 |
0.00 |
ADME/T ≤ 10μM
|
Z81057-2-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #2 Of 5), Other |
Other |
5 |
0.51 |
ADME/T ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3 |
0.52 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.47 |
5.32 |
-10.67 |
1 |
5 |
0 |
57 |
316.353 |
6 |
↓
|
|
|
Analogs
-
967733
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 30 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TOP1-1-E |
DNA Topoisomerase 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4000 |
0.26 |
Binding ≤ 10μM
|
Z80014-1-O |
A204 (Rhabdomyosarcoma Cells) (cluster #1 Of 1), Other |
Other |
20 |
0.37 |
Functional ≤ 10μM
|
Z80019-1-O |
A-427 (Lung Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
1 |
0.43 |
Functional ≤ 10μM
|
Z80021-2-O |
A498 (Renal Carcinoma Cells) (cluster #2 Of 5), Other |
Other |
126 |
0.33 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
5 |
0.40 |
Functional ≤ 10μM
|
Z80045-1-O |
BT-20 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
316 |
0.31 |
Functional ≤ 10μM
|
Z80048-1-O |
BXPC-3 (Pancreatic Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
79 |
0.34 |
Functional ≤ 10μM
|
Z80056-1-O |
CAKI-2 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
5012 |
0.26 |
Functional ≤ 10μM
|
Z80086-1-O |
CFPAC-1 (Pancreatic Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
5 |
0.40 |
Functional ≤ 10μM
|
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
158 |
0.33 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
4 |
0.41 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
19 |
0.37 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
670 |
0.30 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
9 |
0.39 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
398 |
0.31 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
370 |
0.31 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
79 |
0.34 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
8 |
0.39 |
Functional ≤ 10μM
|
Z80316-1-O |
NCI-H128 (cluster #1 Of 1), Other |
Other |
6 |
0.40 |
Functional ≤ 10μM
|
Z80381-1-O |
PANC-1 (Pancreatic Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
7943 |
0.25 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
36 |
0.36 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
4 |
0.41 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
720 |
0.30 |
Functional ≤ 10μM
|
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
6 |
0.40 |
Functional ≤ 10μM
|
Z80539-1-O |
T98G (Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
1 |
0.43 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
8 |
0.39 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
40 |
0.36 |
Functional ≤ 10μM
|
Z80640-1-O |
786-0 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
5 |
0.40 |
Functional ≤ 10μM
|
Z80661-1-O |
A704 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
10000 |
0.24 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
88 |
0.34 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
3190 |
0.27 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM
|
Z80800-1-O |
MIA PaCa-2 (Pancreatic Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
251 |
0.32 |
Functional ≤ 10μM
|
Z80847-1-O |
FaDu (Pharyngeal Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
1 |
0.43 |
Functional ≤ 10μM
|
Z80891-1-O |
H4 (Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
316 |
0.31 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
7 |
0.39 |
Functional ≤ 10μM
|
Z80991-1-O |
Hs-578T (Breast Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
501 |
0.30 |
Functional ≤ 10μM
|
Z80996-1-O |
HT1197 (Bladder Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
10000 |
0.24 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
251 |
0.32 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
80 |
0.34 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
3162 |
0.27 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
39 |
0.36 |
Functional ≤ 10μM
|
Z81248-1-O |
Malme-3M (Melanoma Cells) (cluster #1 Of 3), Other |
Other |
6310 |
0.25 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
5012 |
0.26 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
79 |
0.34 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.67 |
5.17 |
-12.57 |
2 |
7 |
0 |
102 |
392.411 |
2 |
↓
|
|
|
Analogs
-
35572125
-
-
35643838
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 9 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HIF1A-1-E |
Hypoxia-inducible Factor 1-alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
60 |
0.33 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
50 |
0.33 |
Binding ≤ 10μM
|
Z100519-1-O |
KETR3 (Renal Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
5 |
0.37 |
Functional ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
13 |
0.36 |
Functional ≤ 10μM
|
Z80019-1-O |
A-427 (Lung Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
49 |
0.33 |
Functional ≤ 10μM
|
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
300 |
0.29 |
Functional ≤ 10μM
|
Z80039-1-O |
BGC-823 (Stomach Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
3800 |
0.24 |
Functional ≤ 10μM
|
Z80105-1-O |
COR-L23 (Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
20 |
0.35 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
1200 |
0.27 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
63 |
0.33 |
Functional ≤ 10μM
|
Z80152-1-O |
HCT-8 (Ileocecal Adenocarcinoma) (cluster #1 Of 2), Other |
Other |
74 |
0.32 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
52 |
0.33 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
880 |
0.27 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
1700 |
0.26 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
440 |
0.29 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
601 |
0.28 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
36 |
0.34 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
5550 |
0.24 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
38 |
0.34 |
Functional ≤ 10μM
|
Z80316-1-O |
NCI-H128 (cluster #1 Of 1), Other |
Other |
31 |
0.34 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
45 |
0.33 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
45 |
0.33 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
26 |
0.34 |
Functional ≤ 10μM
|
Z80482-2-O |
SK-MEL-2 (Melanoma Cells) (cluster #2 Of 4), Other |
Other |
140 |
0.31 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
48 |
0.33 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
150 |
0.31 |
Functional ≤ 10μM
|
Z80548-1-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
1500 |
0.26 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
500 |
0.28 |
Functional ≤ 10μM
|
Z80596-1-O |
WISH (Amniotic Epithelial Cells) (cluster #1 Of 1), Other |
Other |
1300 |
0.27 |
Functional ≤ 10μM
|
Z80623-1-O |
Panel (56 Tumour Cell Lines) (cluster #1 Of 1), Other |
Other |
160 |
0.31 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
87 |
0.32 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
78 |
0.32 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
104 |
0.32 |
Functional ≤ 10μM
|
Z80799-1-O |
RPMI 8402 (Pre-T-lymphoblastoid Cells) (cluster #1 Of 1), Other |
Other |
21 |
0.35 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
1100 |
0.27 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
56 |
0.33 |
Functional ≤ 10μM
|
Z81020-7-O |
HepG2 (Hepatoblastoma Cells) (cluster #7 Of 8), Other |
Other |
60 |
0.33 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
7100 |
0.23 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
8700 |
0.23 |
Functional ≤ 10μM
|
Z81084-1-O |
KB VCR R (cluster #1 Of 1), Other |
Other |
339 |
0.29 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
70 |
0.32 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
9 |
0.36 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
5 |
0.37 |
Functional ≤ 10μM
|
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
79 |
0.32 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
1600 |
0.26 |
Functional ≤ 10μM
|
Z81248-1-O |
Malme-3M (Melanoma Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.27 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
3 |
0.38 |
Functional ≤ 10μM
|
Z81342-1-O |
Tumour Cell Lines (cluster #1 Of 1), Other |
Other |
40 |
0.33 |
Functional ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
3100 |
0.25 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.31 |
6.39 |
-40.99 |
3 |
8 |
0 |
108 |
422.461 |
3 |
↓
|
Mid
Mid (pH 6-8)
|
2.31 |
4.23 |
-51.04 |
2 |
8 |
0 |
107 |
421.453 |
3 |
↓
|
Mid
Mid (pH 6-8)
|
2.31 |
2.6 |
-55.53 |
2 |
8 |
0 |
105 |
421.453 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 31 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.19 |
6.98 |
-9.07 |
0 |
3 |
0 |
39 |
233.274 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 19 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TBA1A-2-E |
Tubulin Alpha-3 Chain (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
5700 |
0.35 |
Binding ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
760 |
0.41 |
Functional ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
760 |
0.41 |
Functional ≤ 10μM
|
Z101973-1-O |
Paracentrotus Lividus (cluster #1 Of 1), Other |
Other |
5 |
0.55 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
10000 |
0.33 |
Functional ≤ 10μM
|
Z50587-1-O |
Homo Sapiens (cluster #1 Of 9), Other |
Other |
33 |
0.50 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
100 |
0.47 |
Functional ≤ 10μM
|
Z80186-10-O |
K562 (Erythroleukemia Cells) (cluster #10 Of 11), Other |
Other |
82 |
0.47 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
90 |
0.47 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
80 |
0.47 |
Functional ≤ 10μM
|
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
70 |
0.48 |
Functional ≤ 10μM
|
Z80427-1-O |
RKO (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
110 |
0.46 |
Functional ≤ 10μM
|
Z80466-4-O |
SF268 (cluster #4 Of 4), Other |
Other |
300 |
0.43 |
Functional ≤ 10μM |
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.47 |
Functional ≤ 10μM |
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
120 |
0.46 |
Functional ≤ 10μM |
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
87 |
0.47 |
Functional ≤ 10μM |
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
173 |
0.45 |
Functional ≤ 10μM |
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
68 |
0.48 |
Functional ≤ 10μM |
Z81054-2-O |
SF-268 (Glioblastoma Cells) (cluster #2 Of 3), Other |
Other |
300 |
0.43 |
Functional ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
140 |
0.46 |
Functional ≤ 10μM
|
Z81187-1-O |
LT12 Tumor Cell Line (cluster #1 Of 1), Other |
Other |
50 |
0.49 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.96 |
4.96 |
-14.18 |
2 |
6 |
0 |
87 |
301.327 |
3 |
↓
|
Ref
Reference (pH 7)
|
2.96 |
4.96 |
-10.99 |
2 |
6 |
0 |
87 |
301.327 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 26 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HDAH-1-B |
Histone Deacetylase-like Amidohydrolase (cluster #1 Of 2), Bacterial |
Bacteria |
1300 |
0.43 |
Binding ≤ 10μM
|
B1WBY8-1-E |
Histone Deacetylase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
HDA10-1-E |
Histone Deacetylase 10 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
72 |
0.53 |
Binding ≤ 10μM
|
HDA11-3-E |
Histone Deacetylase 11 (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
50 |
0.54 |
Binding ≤ 10μM
|
HDAC1-3-E |
Histone Deacetylase 1 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
HDAC2-4-E |
Histone Deacetylase 2 (cluster #4 Of 4), Eukaryotic |
Eukaryotes |
921 |
0.44 |
Binding ≤ 10μM |
HDAC3-2-E |
Histone Deacetylase 3 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
HDAC4-2-E |
Histone Deacetylase 4 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
HDAC5-1-E |
Histone Deacetylase 5 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
50 |
0.54 |
Binding ≤ 10μM
|
HDAC6-2-E |
Histone Deacetylase 6 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
90 |
0.52 |
Binding ≤ 10μM
|
HDAC7-3-E |
Histone Deacetylase 7 (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
HDAC8-1-E |
Histone Deacetylase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
820 |
0.45 |
Binding ≤ 10μM
|
HDAC9-3-E |
Histone Deacetylase 9 (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
65 |
0.53 |
Binding ≤ 10μM
|
NCOR2-1-E |
Nuclear Receptor Corepressor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
34 |
0.55 |
Binding ≤ 10μM
|
Q5RJZ2-1-E |
Histone Deacetylase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
Q7K6A1-1-E |
Histone Deacetylase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
100 |
0.52 |
Binding ≤ 10μM
|
Q94F81-1-E |
Histone Deacetylase HD2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
50 |
0.54 |
Binding ≤ 10μM
|
Q99P97-1-E |
Histone Deacetylase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
440 |
0.47 |
Binding ≤ 10μM
|
Q9XYC7-1-E |
Histone Deacetylase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
59 |
0.53 |
Binding ≤ 10μM
|
Q9ZTP8-1-E |
Histone Deacetylase HD1B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
30 |
0.55 |
Binding ≤ 10μM
|
HDA10-1-E |
Histone Deacetylase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDA11-1-E |
Histone Deacetylase 11 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC1-1-E |
Histone Deacetylase 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC2-1-E |
Histone Deacetylase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC3-1-E |
Histone Deacetylase 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC4-1-E |
Histone Deacetylase 4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC5-1-E |
Histone Deacetylase 5 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC6-1-E |
Histone Deacetylase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC7-1-E |
Histone Deacetylase 7 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC8-1-E |
Histone Deacetylase 8 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
HDAC9-1-E |
Histone Deacetylase 9 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7200 |
0.38 |
Functional ≤ 10μM
|
Q94F81-2-E |
Histone Deacetylase HD2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
50 |
0.54 |
Functional ≤ 10μM
|
Z102015-1-O |
Plasmodium Vivax (cluster #1 Of 1), Other |
Other |
170 |
0.50 |
Functional ≤ 10μM
|
Z103205-2-O |
A431 (cluster #2 Of 4), Other |
Other |
4200 |
0.40 |
Functional ≤ 10μM
|
Z103348-2-O |
NCI-H2122 (cluster #2 Of 2), Other |
Other |
7500 |
0.38 |
Functional ≤ 10μM
|
Z50136-2-O |
Plasmodium Falciparum (isolate FcB1 / Columbia) (cluster #2 Of 3), Other |
Other |
820 |
0.45 |
Functional ≤ 10μM
|
Z50425-5-O |
Plasmodium Falciparum (cluster #5 Of 22), Other |
Other |
800 |
0.45 |
Functional ≤ 10μM
|
Z80054-4-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
8100 |
0.38 |
Functional ≤ 10μM
|
Z80064-7-O |
CCRF-CEM (T-cell Leukemia) (cluster #7 Of 9), Other |
Other |
950 |
0.44 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
2120 |
0.42 |
Functional ≤ 10μM
|
Z80156-4-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #4 Of 12), Other |
Other |
1200 |
0.44 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
2400 |
0.41 |
Functional ≤ 10μM
|
Z80166-4-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #4 Of 12), Other |
Other |
2000 |
0.42 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
750 |
0.45 |
Functional ≤ 10μM
|
Z80224-6-O |
MCF7 (Breast Carcinoma Cells) (cluster #6 Of 14), Other |
Other |
8500 |
0.37 |
Functional ≤ 10μM
|
Z80244-1-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #1 Of 7), Other |
Other |
5000 |
0.39 |
Functional ≤ 10μM
|
Z80322-1-O |
NCI-H358 (Lung Carcinama Cells) (cluster #1 Of 2), Other |
Other |
2500 |
0.41 |
Functional ≤ 10μM
|
Z80390-3-O |
PC-3 (Prostate Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
6500 |
0.38 |
Functional ≤ 10μM
|
Z80418-9-O |
RAW264.7 (Monocytic-macrophage Leukemia Cells) (cluster #9 Of 9), Other |
Other |
760 |
0.45 |
Functional ≤ 10μM
|
Z80475-2-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #2 Of 3), Other |
Other |
2100 |
0.42 |
Functional ≤ 10μM
|
Z80493-3-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #3 Of 6), Other |
Other |
2500 |
0.41 |
Functional ≤ 10μM
|
Z80513-1-O |
SQ20B (cluster #1 Of 1), Other |
Other |
3000 |
0.41 |
Functional ≤ 10μM
|
Z80514-1-O |
St-4 (Stomach Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
5200 |
0.39 |
Functional ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 11), Other |
Other |
868 |
0.45 |
Functional ≤ 10μM
|
Z80838-1-O |
EOL1 (Eosinophilic Cells) (cluster #1 Of 1), Other |
Other |
1000 |
0.44 |
Functional ≤ 10μM
|
Z80857-1-O |
Friend Leukemia Cell Line (cluster #1 Of 2), Other |
Other |
990 |
0.44 |
Functional ≤ 10μM
|
Z80874-3-O |
CEM (T-cell Leukemia) (cluster #3 Of 7), Other |
Other |
1900 |
0.42 |
Functional ≤ 10μM
|
Z80877-1-O |
NCI-H1299 (Non-small Cell Lung Carcinoma) (cluster #1 Of 2), Other |
Other |
7240 |
0.38 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2060 |
0.42 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
900 |
0.45 |
Functional ≤ 10μM
|
Z81020-4-O |
HepG2 (Hepatoblastoma Cells) (cluster #4 Of 8), Other |
Other |
9300 |
0.37 |
Functional ≤ 10μM
|
Z81024-2-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #2 Of 8), Other |
Other |
3448 |
0.40 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
2600 |
0.41 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
2300 |
0.42 |
Functional ≤ 10μM
|
Z81170-3-O |
LNCaP (Prostate Carcinoma) (cluster #3 Of 5), Other |
Other |
580 |
0.46 |
Functional ≤ 10μM
|
Z81184-5-O |
LOX IMVI (Melanoma Cells) (cluster #5 Of 5), Other |
Other |
1300 |
0.43 |
Functional ≤ 10μM
|
Z81245-4-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #4 Of 6), Other |
Other |
1900 |
0.42 |
Functional ≤ 10μM
|
Z81247-6-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #6 Of 9), Other |
Other |
460 |
0.47 |
Functional ≤ 10μM
|
Z81252-6-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #6 Of 11), Other |
Other |
2200 |
0.42 |
Functional ≤ 10μM
|
Z81280-3-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #3 Of 3), Other |
Other |
3480 |
0.40 |
Functional ≤ 10μM
|
Z81281-4-O |
NCI-H23 (Non-small Cell Lung Carcinoma Cells) (cluster #4 Of 5), Other |
Other |
383 |
0.47 |
Functional ≤ 10μM
|
Z81283-1-O |
NCI-H522 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
832 |
0.45 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.46 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
3900 |
0.40 |
Functional ≤ 10μM
|
Z80957-2-O |
HMEC (Microvascular Endothelial Cells) (cluster #2 Of 2), Other |
Other |
1300 |
0.43 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.47 |
4.41 |
-18.87 |
3 |
5 |
0 |
78 |
264.325 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
71 |
0.45 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
71 |
0.45 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
71 |
0.45 |
Functional ≤ 10μM
|
Z80017-2-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
570 |
0.40 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
2300 |
0.36 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
990 |
0.38 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
98 |
0.45 |
Functional ≤ 10μM
|
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
3800 |
0.34 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
98 |
0.45 |
Functional ≤ 10μM
|
Z80493-3-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #3 Of 6), Other |
Other |
980 |
0.38 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
530 |
0.40 |
Functional ≤ 10μM
|
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
510 |
0.40 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
580 |
0.40 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
190 |
0.43 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
189 |
0.43 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.34 |
-0.53 |
-51.34 |
2 |
4 |
1 |
46 |
294.378 |
4 |
↓
|
|